These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. Gajl-Peczalska KJ, Hansen JA, Bloomfield CD, Good RA. J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499 [Abstract] [Full Text] [Related]
5. Immunological characterization of lymphoproliferative disorders by membrane markers. Huber H, Michlmayr G, Huber C, Falkensammer M. Klin Wochenschr; 1976 Aug 01; 54(15):699-708. PubMed ID: 790006 [Abstract] [Full Text] [Related]
6. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors. Heier HE, Klepp R, Gundersen S, Godal T, Normann T. Scand J Haematol; 1977 Feb 01; 18(2):137-48. PubMed ID: 138931 [Abstract] [Full Text] [Related]
9. Immunologic surface markers in non-Hodgkin's lymphomas. Cossman J, Schnitzer B, Deegan MJ. Am J Pathol; 1977 Apr 01; 87(1):19-32. PubMed ID: 322504 [Abstract] [Full Text] [Related]
10. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Lukes RJ, Parker JW, Taylor CR, Tindle BH, Cramer AD, Lincoln TL. Semin Hematol; 1978 Oct 01; 15(4):322-51. PubMed ID: 366759 [No Abstract] [Full Text] [Related]